nasdaq

Mawson Infrastructure Group Inc. Announces Compliance with Nasdaq Continued Listing Requirements

December 22, 2025 14:05 ET  | Source: Mawson Infrastructure Group Inc. MIDLAND, Pa., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Mawson…

3 months ago

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 19, 2025 16:15 ET  | Source: Zenas BioPharma WALTHAM, Mass., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc.…

3 months ago

Synergy CHC Corp. (NASDAQ: SNYR) Appoints Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin America

Role Supports Synergy’s Expanding Presence in Mexico, Including Initial Product Shipments to Costco Mexico December 16, 2025 08:00 ET  |…

3 months ago

Society Pass Incorporated (Nasdaq: SOPA) Rolls Out M&A Strategy to Capture Potential Significant Valuation Opportunities in Global Landscape of Privately Held Companies

December 15, 2025 10:55 ET  | Source: Society Pass Incorporated NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- As part…

3 months ago

Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

December 12, 2025 16:30 ET  | Source: Zevra Therapeutics CELEBRATION, Fla., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc.…

3 months ago

Receipt of Delinquency Notification from Nasdaq

Singapore, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), today announced that it has…

4 months ago

Fusemachines Files Q3 2025 Quarterly Report and Discloses Nasdaq Notice

November 28, 2025 16:05 ET  | Source: Fusemachines NEW YORK, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Fusemachines Inc. (“Fusemachines” or…

4 months ago

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

November 28, 2025 08:00 ET  | Source: Spero Therapeutics, Inc. CAMBRIDGE, Mass., Nov. 28, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics,…

4 months ago

Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules

$4.25 million upfront with up to an additional $4.1 million of potential aggregate gross proceeds upon the exercise in full…

4 months ago

Darkiris Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Hong Kong, Nov. 21, 2025 (GLOBE NEWSWIRE) -- DarkIris Inc. (Nasdaq: DKI) (the “Company” or “DarkIris”), a comprehensive technology enterprise…

4 months ago